The initial treatment of Parkinson's disease should begin with levodopa
- 1 September 1999
- journal article
- case report
- Published by Wiley in Movement Disorders
- Vol. 14 (5) , 716-724
- https://doi.org/10.1002/1531-8257(199909)14:5<716::aid-mds1002>3.0.co;2-q
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Ropinirole for the Treatment of Early Parkinson Disease: A 12-Month ExperienceArchives of Neurology, 1998
- Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled studyMovement Disorders, 1998
- Is levodopa toxic to human substantia nigra?Movement Disorders, 1997
- Absence of neurotoxicity of chronic L-DOPA in 6-hydroxydopaminelesioned ratsNeuroReport, 1997
- A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's diseaseMovement Disorders, 1994
- Early combination therapy with bromocriptine and levodopa in parkinson's diseaseMovement Disorders, 1993
- A Nationwide Collaborative Study on the Long-Term Effects of Bromocriptine in Patients with Parkinson’s DiseaseEuropean Neurology, 1991
- Subcutaneous apomorphine in the treatment of Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years.Journal of Neurology, Neurosurgery & Psychiatry, 1989